Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial ...
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. To highlight the FDA ...
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently. This content is an AI-generated, fully rewritten summary based ...
Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology ...
New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration AstraZeneca is the first major global biopharma to establish ...
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. This content is an ...
“What has kept me in the industry for almost 30 years now is really that sense of passion – and the patient at the end of it. What gets me up in the morning is knowing that we’re doing things that ...
Moderna has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ...
The biopharmaceutical industry currently finds itself at a precarious intersection of unprecedented innovation and antiquated validation. We have unlocked unprecedented capabilities in gene editing ...
We are all watching the rise of oral, small molecule GLP-1 receptor agonists with justified interest. The promising phase III results of Eli Lilly’s orforglipron has set the pace, and others are ...
I often describe regulatory strategy as the invisible skeleton of a biotechnology company. When it is well-formed, you hardly notice it is there, yet it provides the essential structure that allows ...
Scientists worldwide have condemned suggestions from Donald Trump that Tylenol is a cause of autism. The FDA has said it is initiating a label change for acetaminophen products to reflect an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results